Facility along Cambridge Street will provide exceptional care, increased capacity and strengthen ties to West End and Beacon Hill neighborhoods.
For more than 100 years, researchers at the Massachusetts General Hospital Corrigan Minehan Heart Center have conducted groundbreaking research and clinical trials to diagnose, treat and prevent heart disease.
Working to End Heart Disease
From pioneering technologies that monitor heart failure patients at home to discovering a master cell that has shown a promising ability to repair damaged heart tissue, Corrigan Minehan Heart Center research has led to major advances in cardiovascular medicine.
Our research focuses on:
- Understanding what leads to heart disorders
- Identifying new treatments for heart disease
- Repairing damaged hearts and blood vessels
- Uncovering new minimally invasive treatment options
The Corrigan Minehan Heart Center conducts the full range of research—from basic investigation that improves our understanding of the causes of cardiovascular disease to translational research that brings new discoveries to the bedside for the benefit of patients.
Breakthroughs at the Cardiovascular Research CenterWith more than 35,000 square feet dedicated to investigating heart disease, the Cardiovascular Research Center (CVRC) is the major research arm of the Corrigan Minehan Heart Center. CVRC breakthroughs have led to new treatments for heart disease and related disorders such as diabetes. Learn more about the Cardiovascular Research Center.
Mass General researchers are studying the genetic basis of atrial fibrillation and defining new treatment approaches, such as catheter ablation and left atrial appendage exclusion, for this condition.
Cardiac Resynchronization Therapy
We are developing new technologies to monitor heart failure patients remotely and improve the efficiency of cardiac devices used to treat heart failure.
Preventing Heart Disease
Understanding the genetics of heart disease means that we can identify heart disease patients earlier and help prevent this condition in their children. We are also working to prevent heart disease in women from low-income Boston neighborhoods.
Learn more about the Cardiovascular Disease Prevention Center
Learn more about the Corrigan Women’s Heart Health Program
Adult Congenital Heart Disease
At the Corrigan Minehan Heart Center, we are investigating new devices to treat congenital heart defects. We also helped found a worldwide registry that enables researchers to conduct long-term studies of adults who have grown up with this condition.
Learn more about the Adult Congenital Heart Disease Program
Our research focuses on preventing cardiac events in professional athletes and highly active patients, from college students to seniors.
Coronary Artery Disease
Our studies of stem cells and genetic risk factors help us understand why people develop heart disease. We are also leading a major clinical trial to learn how type II diabetes impacts heart disease.
Heart Failure and Transplant
Mass General is one of a few select hospitals in the nation to receive a National Institutes of Health grant to study heart transplantation. Our research explores improving the success of heart transplants in patients who are at high risk of organ rejection. We are also part of a network of advanced centers for heart failure research created by the National Heart, Lung, and Blood Institute.
Corrigan Minehan Heart Center investigators are evaluating a unique, minimally invasive procedure called transcatheter aortic valve replacement as a treatment option for patients with severe aortic valve stenosis who are not candidates for open-heart surgery.
We are discovering new ways to diagnose heart attacks within minutes, instead of hours, and are uncovering the genetic makeup of hypertrophic cardiomyopathy.
Thoracic Aortic Disease
Researchers at the Corrigan Minehan Heart Center helped found an international registry of patients with thoracic aortic disease that tracks thousands of cases and guides treatment direction to physicians worldwide.
Related News and Articles
- Press Release
- Sep | 23 | 2022
The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
- Patient Education
- May | 24 | 2022
On May 24, 2022, the Massachusetts General Hospital Transplant Center held a virtual, fireside chat to share the latest updates on COVID-19 and transplantation.
- Press Release
- Apr | 18 | 2022
Women who had experienced infertility had a 16% increased risk of heart failure compared with women who did not have an infertility history.
- Press Release
- Mar | 3 | 2022
Handheld devices for A-fib screening may be most effective in the oldest adults during primary care visits
Advanced consumer technology has produced small electrocardiogram devices that could be efficiently deployed in point-of-care screening for atrial fibrillation, though the proportion of cases detected among all patients 65 and older is small.
- Press Release
- Mar | 2 | 2022
Mutations in genes that direct the production of fibrillar collagens, essential components of blood vessel walls, appear to predispose individuals to SCAD.